Effects of busptrone and chlordzazepoxtde on plasma catecholamine and corncosterone levels m stressed and nonstressed rats PHARMACOL BIOCHEM BEHAV 38(2) 299-308, 1991 --The effects of mtragastnc administration of the prototyplcal benzodlazepme (BDZ) anxlolytlc drug chlordlazepoxlde (CDP) and the non-BDZ anxlolytlc agent busplrone (BUSP) on basal and stress-elevated plasma noradrenahne (NA), adrenahne (A) and cortlcosterone (CS) contents were investigated. Acute dosing of CDP (1-27 mg/kg) produced dose-related increases m basal CS secretion but was without effect on basal NA levels The high dose of CDP caused a shght short-term A increase Dose-dependent increases in plasma A, NA and CS contents were observed after acute treatment with BUSP (2 and 20 mg/kg) A medium dose of CDP (9 mg/kg) attenuated the stress-reduced CS and A elevations High doses of CDP that elevated basal CS release prevented a further increase of CS by stress and inhibited the NA and A response to stress. BUSP (2 and 20 mg/kg) was not effecuve in decreasing the stressehclted rise of CS, NA or A Conversely, the 20 mg/kg dose of BUSP enhanced the stress-reduced A response Repeated administration of CDP (9 mg/kg/day for six days) produced tolerance to the elevation of basal CS triggered by acute CDP treatment, but increased the efficacy of the drug's CS and A attenuating action m stressed rats Repeated admlmstratlon of BUSP (2 mg/kg/day for s~x days) also produced tolerance to the acute BUSP-mduced effect on basal CS release, but dtd not affect the stress-induced CS. NA and A responses. It is concluded that the clinically effecnve anxlolytlc BUSP does not have the BDZ-hke property to lnhth~t stress-induced elevations in CS, NA and A. Furthermore, the present data support other evidence that activation of 5-HTIA receptor mechanisms mcreases plasma catecholamlne and cort~costerone concentrations Noradrenallne Adrenahne Cortlcosterone Chlordlazepoxlde Busplrone Stress Rat
THE novel anxiolytlc drug buspirone (BUSP) has a chemical structure and a neuropharmacological mechanism of action different from that of the prototypical benzodiazepine (BDZ) chlordlazepoxlde (CDP) [see (15) for review]. BUSP, a 5-HTIA receptor hgand, was reported to possess potent BDZ-like activity m animal behavioral tests of anxlolytic efficacy, and to be devoid of the sedative, anticonvulsant, muscle-relaxant and addicting effects typical of BDZs (15, 18, 48) .
Whereas BDZs and BUSP both have various behavioral effects indicative of anxiolytic activity, the BDZs are also known to have effects on circulating stress-related hormones such as the glucocort~cold corticosterone (CS) and the catecholammes noradrenaline (NA) and adrenaline (A). In general, acute administration of low to moderate doses of BDZs block or attenuate stressinduced elevations in these hormones (4, 10, 16, 17, 24, 27, 28, 30, 32, 35, 39, 44, 47), while relatively high doses of BDZs cause an enhancement of CS secretion in unstressed animals (30, 32, 39, 44). The former effect has been considered to reflect the anxlolytic property of BDZs, whilst the latter effect has been attributed to their sedative/ataxlc action (20, 28, 30) . In accordance with this view are results regarding the effects of repeated (subchronic) BDZ administration on glucocortlcoid secretion. Most investigators have reported that tolerance develops rapidly to the BDZ-induced elevation in basal CS concentrations but not or at least less quickly/complete to their glucocorticoid-attenuatlng action in stressed rats (4, 16, 28, 32).
The neuroendocrine effects of BUSP, however, have not been clearly estabhshed. Although acute administration of BUSP conSlstently produced dose-dependent increases in basal CS secretion (26, 33, 45) , the effects of this drug on stress-induced CS elevations are scarce and conflicting; i.e., either a small inhibition (45) or no effect at all (33). In addition, no data are available concerning the effects of BUSP on basal and stress-elevated plasma NA and A concentrations. The present series of experiments were designed to determine the effects of acute as well as of subchronic BUSP and CDP administration on the dynamics of plasma NA, A and CS concentrations in unstressed and stressed rats.
METHOD

Animals and Housing
Male Wistar rats (Harlan-CPB, Zeist, The Netherlands) weighing 250-275 g on their arrival In the laboratory were used as subjects. They were housed individually in clear Plexxglas cages (25 x 25 x 30 cm) on a layer of woodshavmgs. For at least two weeks prior to surgery, cages were placed in a room under condiuons of constant temperature (21_ 2°C) and a fixed 12-h light/ dark photoperiod (lights on at 7:00 a.m ). Subjects were in full view, sound and smell of each other, had free access to food and water at all times and were handled daily for weighing purposes.
Surgery and Blood Sampling
Under Hypnorm anesthesia (10 mg/kg fluamsone and 0.2 mg/ kg fentanyl) and preme&cated with atropine (1 mg/kg) and &az-epam (5 mg/kg), animals were provided with a silastic cannula Q.d. 0.5 mm, o.d. 0.9 mm, Dow Coming, USA) into the entrance of the right atrium via an external jugular venotomy according to the techniques basically described by Steffens (40).
This cannula allows frequent withdrawal of small amounts of blood without disturbing the animal either behaviorally or physiologically (40,49). Animals were also provided with a sihcon cannula (1.d. 0.8 ram; o d. 1.4 mm) into the antrum wall of the stomach The outer ends of both cannulae were extended subcutaneously to emerge at the top of the head and anchored to the skull (43). This indwelling catheter allows intragastnc drug administration in the freely behaving and undisturbed rat. After surgery, the rats were allowed to recover for at least one week before the start of the expenments. Dunng this period, animals were accustomed to the blood samphng procedure At least ninety minutes before an expenment, the indwelling cannulae were extended with polyethylene tubes (1 0.5 m; o.d. 1.45 mm; i d. 0 75 ram) allowing blood sampling and intragastrlc drug infusion. Blood samples of 0.35 ml were withdrawn for determination of NA, A and CS concentrations. Immediately after each blood sample an equal volume of bepannized (12.5 IU/ ml) blood, freshly obtained from a cannulated donor rat, was transfused through the catheter At the end of the expenment, the indwelling part of the heart cannula was filled with 0.9% (w/v) NaC1 containing 500 IU heparin/ml plus 60% polyvmylpyrrohdone (Merck, Darmstadt, FRG). The indwelling part of the stomach catheter was filled with 0.9% saline.
Drugs
Chlordlazepoxide hydrochlonde (Hoffmann-La Roche, Basel, Switzerland) and buspirone hydrochloride (Bnstol-Myers, Evansville, IN) were dissolved m physiological saline. The vehicle FIG 2 Time course of plasma CDP levels (as determined by benzo&az-epme radloreceptor assay) following acute mtragastnc admlmstratton of 9 or 27 mg/kg chlordlazepoxlde (CDP) to unstressed rats Data are expressed as mean-SEM for I 1 ammals Results from ANOVA are as follows F(dose)( 1.10l = 31 8, p<0 001, F(tlme)(5,6) = 65 4, p<0 001, F(dose × rime)(5,6) = 9 00, p<0 05 *Indicates significant (at least p<0 05) differences between the two doses consisted of an ao&fied (HC1) saline solution with a similar acidity as the respective drug solutions (pH 3.2-3.9). Solutions were freshly prepared before every test In order to minimize the nondrug-related stress associated w~th the most commonly used methods of drug administration (e,g.. handling, IP or SC Injection, orogastric mtubation), drug and vehicle solutions were administered via an mtragastrlc cannula in a volume of 2 ml/kg.
Experimental Procedures
All experiments were performed in the light period between 9'00am. and 100pm
Experiment 1 Effects of CDP and BUSP on Plasma CA and CS Levels m Unstressed Rats
Twenty subjects were used in this experiment. Twelve animals were sampled under vehicle and 4 doses of CDP (1, 3, 9 and 27 mg/kg), and eight animals under vehicle and 2 doses of BUSP (2 and 20 mg/kg), using a randomized repeated measures within-subject design with an mtertest interval of 1 week. Immediately after the first blood sampling (t =0 mIn; baseline), drug or vehicle solutions were slowly (10 s) infused wa the lntragastnc cannula. Subsequent blood samples were taken at t= 15, 30, 60, 120 and 180 mm following drug admimstration while the animals remained undisturbed in their home cages
Experiment 2 Effects of CDP and BUSP on Novelty Stress-lnduced CA and CS Elevations
Twelve subjects were used m this experiment. Six animals were sampled under vehicle and 2 doses of CDP (9 and 27 mg/ kg) and the other six under vehicle and 2 doses of BUSP (2 and 20 mg/kg), using a balanced repeated measures within-subject design with an lntertest interval of 1 week. After the first blood sampling (t = 0), drug or vehicle solutions (2 ml/kg) were slowly (10 s) infused via the intragastnc cannula. Subsequently, animals remained in their home cage for 60 mln, whereafter they were picked up by hand and placed Into an unfamiliar cage for 120 mm (novel environment stress; NES). Blood was sampled at t=59, 61, 90, 120 and 180 min after drug treatment.
Experiment 3. Effects of Acute and Repeated Administration of CDP and BUSP on Basal and Water Stress-Induced CA and CS Release
Two groups of twenty rats each were used In this experiment. Rats in each group received six consecutive daily pretreatments with either vehicle (saline, n = 10) or drug (9 mg/kg CDP or 2 mg/kg BUSP) Dunng the whole experiment only one drug was used for each group. Drug and vehicle solutions were administered lntragastncally at approximately the same time each day. On the test day (l e., day 7), half of the vehicle-and drug-pretreated groups were given vehicle, whereas the other half received drug treatment Thus for each drug-treatment group, a factorial design consisting of the following four subgroups was created (pretreatment/test treatment) A, Vehicle/Vehicle; B, Vehicle/ Drug; C, Drug/Vehicle; D, Drug/Drug. On the test day, immediately after taking the first baseline blood sample (at t = -60 mln), drug or vehicle solutions (2 ml/kg) were slowly infused via the intragastnc cannula After 59 mln (at t = -1 mln) another blood sample was taken from the unstressed animals in their home cages, whereafter (at t = 0 mm) rats were picked up by hand and placed for 15 rain into a new cage containing 5 cm of water of 35-+ 2°C (water stress, WS) Blood samples were taken at t= 1 mIn and t= 15 rain. Following the t= 15 rain blood sample, the rats were returned to their home cages and additional blood samples were taken at t=60 and t= 120 ram.
Chemical Determtnanons
Blood samples were immediately transferred to ice-cooled centrifuge tubes containing 10 Ixl heparln solution (500 IU/ml). For the determmation of plasma catecholamme contents, an aliquot of 250 ILl transferred blood was rapidly plpetted into chilled tubes containing 10 I, tl of a solution of 25 mg/ml &sodmm EDTA and 27.5 mg/ml reduced glutathione in order to prevent CA degradation. The remaining 100 p,l blood was used for the CS and, in case of the CDP experiments, for the BDZ-receptor binding assays After centrifugation (4000 × g for 10 mln at 4°C), supernatants were removed and stored at -30°C until assayed.
The concentrations of NA and A were measured in duplicate In 20 Ixl perchlorlc acid-deprotelnized plasma according to a radloenzymatlc COMT-procedure (12,46). In short, the CAs were converted into their [3H]-methoxy derivatives by incubation with S-adenosyl-L-[methyl-3H]methtonlne (80 Cl/mmol; NEN Chemicals) in the presence of catechol-O-methyltransferase. Labeled products were isolated by organic extraction and paper chromatography. After elutlon of the labeled products, activity was counted in a liquid scintillation analyzer (Philips, The Netherlands). CA concentrations were calculated from net DPM values for samples and internal standards and expressed as pg/ml The intra-and Interassay vanabdittes were less than 10% and 15%, respectively The sensitivity of the assay was 1 pg for both NA and A.
Plasma CS concentrations were determined in duplicate according to a competitive protein-binding method (37) Cortlcoste- 
Statistical Analyses
The response-time patterns of the plasma constituents were evaluated by use of two-way analyses of variance (ANOVA) with drug treatment as within-(Experiments 1 and 2) or as between-(Experiment 3) subject factor and samphng ume as repeated measures within-subject factor. The multivariate model was used for the repeated measures factor (11). Further analyses were made by paired Student t-tests (m&vldual within-group comparisons) or by Duncan's new multiple range test (individual between-group comparisons) to determine the source of the detected significance in the ANOVA's (7). The cntenon of significance was set at p<0.05.
RESULTS
Expertment 1
Under nonstress con&tions, acute mtragastric admimstratlon of CDP (9 and 27 mg/kg) resulted in dose-and time-related elevations of plasma CS levels ( Figure 2 shows the dynanucs of CDP levels expressed as CDP binding equivalents m blood after administration of 9 and 27 mg/ kg CDP. A clear dose-related increase was found for CDP, reachlng peak levels at 20-40 min and remaining h~gh dunng the rest of the sampling period Marked dose-and rime-dependent increases in plasma CS concentranons (Fig. 3A) as well as in plasma NA and A contents (Fig. 3B) were observed following acute admimstrauon of BUSP (2 and 20 mg/kg). Figure 4 shows the dynanucs of BUSP levels expressed as buspirone blndmg eqmvalents m blood after administration of 2 and 20 mg/kg busp~rone. A clear dose-related increase was found, reaching peak levels at t = 15 nun.
Experiment 2
Exposure of vehicle-treated rats to mild stress in the form of a novel environment resulted m rehable plasma CS elevations (slgmficant at t=90 and 120 mm), as well as rapid but trans]ent increases (2.5-fold) in plasma NA (significant at t=61 and 90 nun) and A (signtficant at t = 61 mm) concentrattons (see Figs. 5 and 6). The effects of CDP and BUSP admnustration on these stress-ellc~ted rases in circulating CS, NA and A concentrations are illustrated in Figs. 5 and 6, respectively. Pilot expernuents showed that 1 and 3 mg/kg CDP &d not affect either basal or novelty stress-elevated CS, NA and A concentrations (data not shown). As m Experiment 1, the 9 mg/kg dose of CDP caused a slight increase in basal CS levels but almost completely blocked the novelty-reduced CS release. Furthermore, this dose of CDP s~gnificantly attenuated the A response to NES and tended (p = 0.053) to reduce the NA stress response. The high (27 mg/kg) dose of CDP strongly elevated basal CS release, but prevented a further increase by novelty stress. This dose almost completely inhibited the stress-induced increases m plasma NA and A. One hour (Le., t= 61 blood sample) after admnustration of 9 and 27 mg/kg CDP, plasma levels of CDP were 14 2 _+ 1.6 and 29.6 ___ 3 3 nmol/ml, respectively
The 2 and 20 mg/kg doses of BUSP elevated CS values m a dose-dependent fashion. In marked contrast to CDP, BUSP was not effecnve m attenuating the novelty-ehclted nses of plasma CS, NA and A contents. In fact, the 20 mg/kg dose of BUSP elevated basal A levels and enhanced the A response to stress ( rats. In sallne-pretreated rats the acute admimstratlon of 9 mg/kg of CDP decreased the stress-induced CS and A response. The (shght) mcrease in CS after acute CDP treatment was abohshed in CDP-pretreated rats as compared to the vehlcle-pretreated rats In contrast, six daily CDP pretreatments significantly increased the drug's CS and A attenuating actxon in stressed rats. Similar to what was found in Experiment 2, neither acute nor repeated CDP (9 mg/kg) administration significantly attenuated the NA response to stress However, vehicle administration to CDP-pretreated animals produced an enhancement of the postwater stress NA rise and a prolongation of the stress-induced CS increase Figure 8 illustrates the dynamics of circulating CDP concentrations in the four groups of rats. In the vehicle-pretreated rats. acute CDP administration resulted m elevated plasma CDP values s|mllar m magmtude and t~me pattern as in Experiment l Unexpectedly, slgmficantly h,gher levels were found in CDP-pretreated animals following acute dosing with 9 mg/kg CDP. The effects of 2 mg/kg BUSP or vehicle admmxstratlon on basal and water stress-elevated CS, NA and A release in vehicleand BUSP (2 mg/kg/day for 6 consecuuve days)-pretreated rats are shown In Fig. 8 . Six dally BUSP pretreatments produced tolerance to the acute BUSP-lnduced increment in basal CS secretion. As in Experiment 2, acute BUSP admmlstration did not reduce the stress-elicited rases in CS, NA and A concentrations tn either the BUSP-or Sal-pretreated group. However, irrespective of the acute treatment on day 7, chronic BUSP-pretreated rats showed an acceleration in the return towards basal levels of the stress-elevated CS concentrations Figure l0 illustrates the dynamics of circulating BUSP concentrations in the BUSP/BUSPand Sal/BUSP-treated rats As in Experiment l, acute BUSP (2 mg/kg) admlmstratlon to sahne-pretreated rats caused a slight elevation of BUSP levels at t = 60 mln. In the BUSP-pretreated animals, however, acute BUSP caused no change in plasma BUSP levels.
DISCUSSION
The mare new findings of this study are 1) that BUSP does not have the benzodmzepine-hke property to antagonize the stress-in- The CS-releasmg effects of CDP (27, 28, 32, 44) and BUSP (26, 33, 45) have previously been reported by others using different routes of drug administration (parenteral), different methods of blood sampling (decapitation) and different experimental designs (single injection test interval, between-subjects design). Although CDP and BUSP have similar effects on pituitaryadrenocortical activity in undisturbed rats, these are most likely mediated by different mechanisms of action BUSP has been shown to produce an increase in pituitary-adrenocortical outflow by activating 5-HTIA receptor mechanisms (25, 26, 38), whereas the CS-releasing action of CDP is mediated by central-type BDZ receptors (6,13) in the brain (30,32) While there is general agreement that BDZs can interact with brain 5-HT systems (4, 9. 22, 41), the importance of such an interaction as to the CDP effects on basal CS release is not known yet. Testing for the development of cross-tolerance could give an answer to this question (38).
The dose-dependent increases in plasma A and NA concentrations following BUSP administration suggest that 5-HT~A receptors are involved in the regulation of neurosympathetic and adrenomedullary activity In accordance with this suggestion are the recently reported findings that activation of the 5-HTtA receptor subtype by 8-OH-DPAT (3,8) and m-chloropbenylpiperazme (2) similarly lead to marked increases in concentrations of NA and A m plasma However, it is not yet clear whether the 5-HT receptors mediating such effects are located in the brain, at the sympathetic nerve endings or on the chromaffin cells of the adrenal medullae (2, 8) .
A number of previous studies have shown that BDZs, over a wide dose-range, attenuate the activation of the pituitary-adrenocortical axis that occurs in response to a variety of stressful stimuh, including novelty (4. 16, 17, 35), noise (28, 32, 44), restraint (24), foot-shock (5,27), and forced swimming (30,42). In contrast, information about BDZ anxiolytic drug effects on stress-induced sympatho-adrenal release of catecholamines is scarce in the rat. One study has reported that a low (nonsedating) dose of mldazolam reduced the foot-shock stress-induced plasma A but not the NA response, whereas a higher (sedative/ataxic) dose attenuated both the NA and A stress response (10). In another study it was shown that a relatively high (5 mg/kg, IP), sedative, dose of diazepam decreased the restraint stress-reduced NA but not A response, whereas 1 mg/kg alprazolam inhibited both the NA and A response to restraint stress (47). The present findings that moderate to high doses of CDP oppose the novelty stress and water immersion stress-reduced elevation of CS and A concentrations, whereas only high sedative doses of CDP are effective in reducing the stress-reduced NA rise, are in general agreement with, and extend, the above-mentioned reports A number of investigators have considered inhibition of stress-related hormone secretion to be predictive of or at least closely related to anxiolytlc drug action at a behavioral level (24, 28, 43), while the enhanced CS concentrations in unstressed rats have been attributed to nonspecific stress effects arising from sedation and ataxia (28, 35, 44) In accordance with this view are the results regarding the effects of repeated CDP treatment tolerance develops quickly to the BDZ-induced elevation in CS concentrations but not to the drug's CS-and A-attenuating action in stressed rats [this study, (16,32)] There is general agreement in the literature that tolerance develops very quickly to the sedative properties of BDZs, whereas its anxlolytic effects are still found after relatively shortterm (i e , one week) treatment Surprisingly, in the present study, it was found that repeated CDP treatment (once daily for six days) increased its potency to antagonize the stress-induced CS and A elevations. This increased potency was accompanied by a parallel increase in plasma CDP concentrations following acute dosing with CDP in these pretreated animals. Recently, a similar pharmacokinetic effect was observed in the dog. 1.e., after repeated dosing with dlazepam (1 or 2 mg/ kg PO 3 times daily for one week), maximum drug and metabohte levels were higher than those determined after the first dosing with diazepam (31). Whether this remarkable pharmacokinetic effect after chronic BDZ pretreatment is the result of an increased rate of drug entry into the blood stream or the result of an attenuated metabohsm of the drug is not clear yet Hence, this point remains open to further investigation.
Development of tolerance is often accompanied by the occurrence of signs of withdrawal after discontinuation of drug administration (21). In the case of BDZs, spontaneous withdrawal is characterized by anxlogenic-hke symptoms such as decreased food intake (29), increased body temperature (3 l), changes in motility (29,3 I), as well as increased sympathetic function (19) and raised adrenocortical activity (9,14). In the present study, CDP-withdrawal from subehronically pretreated rats did not affect basal plasma CS, NA and A concentrations, but increased the postwater-stress-lnduced NA response and prolonged the CS elevation in response to water stress. The data, therefore, indicate that withdrawal effects on neurosympathetlc and adrenocortical outflow are only apparent under nonhasal conditions, i.e., when these systems become activated.
Although BUSP was reported to possess potent anxiolytic-hke effects in several animal behavioral models as well as m man without producing the ancillary properties of the BDZs (sedation, myorelaxatlon, addiction), the drug was not found to be effective in attenuating the stress-ehclted rise in CS and/or catecholamine concentrations nn this study Conversely, a high dose of BUSP significantly enhanced the novelty stress-induced A release An additive effect of BUSP and stress has been observed on CS levels (33,45), hut was not replicated in this study. In a previous study it was suggested that the 0.5 mg/kg (IP) dose of BUSP attenuated the CS rise in response to stress (conditioned emotional response paradigm) However, in addition to methodological prob-lems concerning the time-lag between stressor exposure and blood sampling in that study, no significant difference was found between the CS values of the stressed vehicle-treated group and those of the stressed BUSP-treated group. Hence, the concluston about a BUSP-mediated mhibition of stress-related CS release cannot be drawn from that study (45). Stmalar to our results, Matheson and co-workers (33,34) recently found that neither BUSP (1 and 10 mg/kg, IP) nor its structural analog geptrone (1 and 10 mg/kg, IP) nor its principal metabohte 1-(2-pynmtdmyl)-plperazine (1 and 10 mg/kg, IP) had the abihty to blunt the response of CS to rotational stress. However, diazepam (1 and 10 mg/kg) in their hands also did not significantly alter the stress-related increase in CS, thus preventing drawing any definite conclusions from that study about whether or not a diazepam-hke inhibitton for BUSP of stress-related CS release extsts.
Compared to BDZs, BUSP is known to have a delayed onset of action (181 and thus BUSP may need to be adnuntstered over a period of days in order to reach full anxlolytic effectiveness. In the present study, however, a 6-day regimen of BUSP treatment &d not alter the drug's inability to affect the neuroendocnne stress response, although a faster return of the stress-elevated CS levels was seen in the BUSP-pretreated rats irrespective of their acute treatment It is concluded that the chntcally effective anx~olyt~c BUSP does not have the BDZ-hke properly to inhibit stress-Induced elevations m glucocortlcotds and catecholammes. plasma catecholamlne concentrations precede hypotens~on and brady- 
